Hepatitis A
Hepatitis A is an acute liver inflammation caused by infection with the hepatitis A virus (HAV). It is mainly transmitted through the fecal-oral route. It is more common in children and adolescents. It is one of the common intestinal infectious diseases in my country, with the highest incidence and infection rate among viral hepatitis. The source of hepatitis A infection is usually acute patients and subclinical infected persons. The patient is most contagious from the end of the incubation period to 10 days after onset. The fecal-oral route is its main transmission route, and daily life contact is the main transmission route for sporadic cases.
-
Site of disease:
liver -
Infectious :
Contagious -
Frequent population:
All groups -
Related symptoms:
Large liver cell necrosis loss of appetite loss of appetite liver depression and qi stagnation bradycardia -
Concurrent disease:
Related Drugs
Hepatitis A inactivated vaccine
Indication: Active immunization of subjects at risk for hepatitis A virus infection.
Hepatitis A inactivated vaccine (human diploid cells)
Indication: Active immunization of subjects at risk for hepatitis A virus infection.
Inosine Tablets
Indication: This product can directly penetrate the cell membrane into the body cells, activate pyruvate oxidase, so that cells in a low-energy and hypoxic state can continue to metabolize smoothly, and participate in the energy metabolism and protein synthesis of the human body.
Manufacturer:
Shanghai Sine Tianping Pharmaceutical Co., Ltd.
Oleanolic acid tablets
Indication: Used as adjuvant treatment for acute and chronic hepatitis.
Manufacturer:
Jiuzhitang Co., Ltd.
Matrine Sodium Chloride Injection
Indication: Mainly used for the treatment of chronic hepatitis B.
Manufacturer:
Jiangsu Huai'an Shuanghe Pharmaceutical Co., Ltd.
Matrine Glucose Injection
Indication: Used for elevated transaminase and abnormal bilirubin in chronic hepatitis B.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
HAVRIX- hepatitis a vaccine_injection, suspension
Indication: HAVRIX is indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV. HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV).
Manufacturer:
GlaxoSmithKline Biologicals SA
TWINRIX- hepatitis a and hepatitis b (recombinant) vaccine_injection, suspension
Indication: TWINRIX is indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. TWINRIX is approved for use in persons 18 years of age or older. TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus.
Manufacturer:
GlaxoSmithKline Biologicals SA